Experience Search Experience Filter by: Industry Team Airport & AviationAutomotiveEmerging TechnologiesEnergy Food & BeverageHealth CareHospitality, Resort & GolfInsurance & Reinsurance Life SciencesMedical DevicesSports Practice Area Business Law All Business LawEmployee Benefits & Executive CompensationEnvironmental RegulationEstates & TrustsFinance & Financial InstitutionsHealth Care Finance Private Equity & Venture CapitalPublic FinanceReal EstateSecurities, Commodities & Exchange RegulationTaxationTransactional & Securities Government & Public Policy All Government & Public PolicyFDA RegulatoryGovernment ProcurementImmigration, Nationality & Consular Law NHTSA & Motor Vehicle SafetyPublic PolicyStrategic Communications Intellectual Property All Intellectual PropertyBusiness Method & Software PatentsChemical, Biotechnology & PharmaceuticalElectronicsGreen Energy TechnologiesInformation Technology & Outsourcing IP Due DiligenceIP LitigationMechanical & Electromechanical TechnologiesPatent Office TrialsTrademark, Copyright & Advertising Counseling International All InternationalChinaEurope JapanLatin America Litigation All LitigationAntitrustAppellateBankruptcy & Business ReorganizationsBusiness Litigation & Dispute ResolutionConstructionConsumer Financial Services Distribution & FranchiseGovernment Enforcement, Compliance & White Collar DefenseInsurance & Reinsurance LitigationLabor & EmploymentPrivacy, Security & Information ManagementSecurities Enforcement & Litigation Office BostonBrusselsChicagoDetroitJacksonvilleLos AngelesMadison MiamiMilwaukeeNew YorkOrlandoSacramentoSan DiegoSan Diego/Del Mar San FranciscoShanghaiSilicon ValleyTallahasseeTampaTokyoWashington, D.C. Featured All Filters applied: Search phrase entered: Sort results by: Most Recent Most Viewed Most Shared previous123 Defense of Lupron Depot (U.S. Patent No. 4,728,721) Reexamination Reexamination of two patents in parallel litigation covering a pharmaceutical company with $1.5 billion in sales per year. Obtained decision confirming patentability... Global Intellectual Property Strategy for Chinese IT Company Handled the normalization and expansion of an international patenting program for Nationz Technologies Inc. — a major Chinese corporation in the information/technology... Due Diligence for In-Licensing Anemia Drug Licensing of biotechnology drug with up-front payment of $100 million. Represented acquiring company, a global pharmaceutical company, in IP diligence and drafting... Recovery of Insurance Proceeds Successfully represented a commercial policyholder in connection with its efforts to recover under its insurance policy for a theft loss in Japan involving over... General Representation of Biomedical Discovery Company Obtained allowances for EnGeneIC Molecular Delivery Pty Ltd. in the United States, Europe, and Japan for patent claims critical to the client’s global effort to... previous123 Related 1 2 3
Defense of Lupron Depot (U.S. Patent No. 4,728,721) Reexamination Reexamination of two patents in parallel litigation covering a pharmaceutical company with $1.5 billion in sales per year. Obtained decision confirming patentability...
Global Intellectual Property Strategy for Chinese IT Company Handled the normalization and expansion of an international patenting program for Nationz Technologies Inc. — a major Chinese corporation in the information/technology...
Due Diligence for In-Licensing Anemia Drug Licensing of biotechnology drug with up-front payment of $100 million. Represented acquiring company, a global pharmaceutical company, in IP diligence and drafting...
Recovery of Insurance Proceeds Successfully represented a commercial policyholder in connection with its efforts to recover under its insurance policy for a theft loss in Japan involving over...
General Representation of Biomedical Discovery Company Obtained allowances for EnGeneIC Molecular Delivery Pty Ltd. in the United States, Europe, and Japan for patent claims critical to the client’s global effort to...